Creative Planning Boosts Stock Position in Teladoc Health, Inc. (NYSE:TDOC)

Creative Planning raised its holdings in Teladoc Health, Inc. (NYSE:TDOC) by 184.7% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 64,125 shares of the health services provider’s stock after purchasing an additional 41,602 shares during the quarter. Creative Planning’s holdings in Teladoc Health were worth $589,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors have also recently made changes to their positions in the company. Zurcher Kantonalbank Zurich Cantonalbank lifted its holdings in Teladoc Health by 2.1% during the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 65,588 shares of the health services provider’s stock valued at $641,000 after purchasing an additional 1,352 shares during the last quarter. Covestor Ltd boosted its holdings in Teladoc Health by 58.1% in the 1st quarter. Covestor Ltd now owns 3,817 shares of the health services provider’s stock worth $57,000 after buying an additional 1,403 shares during the period. Signaturefd LLC grew its stake in Teladoc Health by 148.7% in the 2nd quarter. Signaturefd LLC now owns 2,868 shares of the health services provider’s stock valued at $28,000 after buying an additional 1,715 shares in the last quarter. Swiss National Bank raised its holdings in Teladoc Health by 0.6% during the 1st quarter. Swiss National Bank now owns 326,902 shares of the health services provider’s stock valued at $4,936,000 after acquiring an additional 1,800 shares during the period. Finally, Arizona State Retirement System raised its holdings in Teladoc Health by 4.2% during the 2nd quarter. Arizona State Retirement System now owns 47,400 shares of the health services provider’s stock valued at $464,000 after acquiring an additional 1,901 shares during the period. 76.82% of the stock is owned by hedge funds and other institutional investors.

Teladoc Health Stock Down 3.7 %

NYSE:TDOC opened at $8.87 on Tuesday. The firm has a 50-day simple moving average of $8.48 and a two-hundred day simple moving average of $9.64. The firm has a market cap of $1.52 billion, a P/E ratio of -1.54 and a beta of 0.90. Teladoc Health, Inc. has a fifty-two week low of $6.76 and a fifty-two week high of $22.54. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.62 and a current ratio of 1.66.

Teladoc Health (NYSE:TDOC) last posted its quarterly earnings results on Wednesday, October 30th. The health services provider reported ($0.19) earnings per share for the quarter, topping the consensus estimate of ($0.29) by $0.10. Teladoc Health had a negative return on equity of 9.40% and a negative net margin of 37.91%. The firm had revenue of $640.51 million during the quarter, compared to analysts’ expectations of $630.50 million. Analysts predict that Teladoc Health, Inc. will post -1.18 earnings per share for the current fiscal year.

Insider Buying and Selling

In other news, CMO Stephany Verstraete sold 15,000 shares of the firm’s stock in a transaction on Wednesday, August 7th. The stock was sold at an average price of $7.60, for a total value of $114,000.00. Following the transaction, the chief marketing officer now directly owns 45,158 shares in the company, valued at $343,200.80. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this link. In other news, COO Michael Willem Waters sold 4,218 shares of the firm’s stock in a transaction on Tuesday, September 3rd. The shares were sold at an average price of $7.16, for a total transaction of $30,200.88. Following the sale, the chief operating officer now directly owns 78,309 shares in the company, valued at $560,692.44. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, CMO Stephany Verstraete sold 15,000 shares of the stock in a transaction on Wednesday, August 7th. The stock was sold at an average price of $7.60, for a total value of $114,000.00. Following the completion of the sale, the chief marketing officer now owns 45,158 shares of the company’s stock, valued at $343,200.80. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 35,051 shares of company stock worth $257,565. 0.95% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

Several research analysts have commented on TDOC shares. Canaccord Genuity Group cut their target price on Teladoc Health from $25.00 to $17.00 and set a “buy” rating for the company in a research note on Thursday, August 1st. Barclays boosted their price objective on shares of Teladoc Health from $10.00 to $12.00 and gave the company an “overweight” rating in a research note on Thursday, October 31st. Royal Bank of Canada increased their target price on shares of Teladoc Health from $9.00 to $10.00 and gave the stock an “outperform” rating in a research note on Wednesday, October 9th. Deutsche Bank Aktiengesellschaft boosted their price target on shares of Teladoc Health from $10.00 to $12.00 and gave the company a “hold” rating in a research report on Friday. Finally, Piper Sandler lowered their price objective on Teladoc Health from $25.00 to $10.00 and set an “overweight” rating on the stock in a research report on Tuesday, August 6th. Fourteen investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, Teladoc Health currently has an average rating of “Hold” and an average price target of $11.97.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.